December 6, 2022
Forbes highlighted research from the University of Cincinnati's Jeffrey Mills and Jeffrey Strawn examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
March 10, 2023
One in 10 adults suffer from the debilitating effects of chronic obstructive pulmonary disease (COPD). Research around a new breathing device developed by pulmonologists at the University of Cincinnati offers promise for improving their lives. The new device not only improves symptoms of breathlessness and quality of life for people with COPD, it also offers benefits for people dealing with stress and anxiety and those practicing mindfulness, meditation or yoga. The research was published in the journal Respiratory Care.
January 6, 2023
Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease. The research was published in Open Forum Infectious Diseases, a journal from the Infectious Diseases Society of America.
January 12, 2024
University of Cincinnati research on how eating strawberries can reduce dementia risk was featured in a "LIVE with Kelly and Mark" segment on superfoods to eat in 2024.
February 9, 2024
Tuberculosis, the main cause of death due to a single pathogen globally, causes more than 1.5 million deaths each year. New research from the University of Cincinnati finds that being in prison or being a former prisoner is responsible for high rates of multidrug resistant TB.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
December 20, 2023
The University of Cincinnati's Francisco Romo-Nava published research in the journal Molecular Psychiatry that found noninvasive spinal cord stimulation is safe and has therapeutic potential to treat depression.
December 21, 2023
U.S. News & World Report highlighted research led by the University of Cincinnati's Francisco Romo-Nava that found spinal cord stimulation was well tolerated and has therapeutic potential to treat depression.
May 3, 2024
The University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
May 23, 2024
Interesting Engineering and Drug Target Review highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researcher Ziyuan Guo that developed the first human mini-brain that incorporates a fully functional blood-brain barrier.